Kane Biotech Inc, a biotechnology company engaged in the research ... New Zealand and the Gulf Cooperation Council (GCC) countries (the Territories). The XSONX Wound Hygiene System is a cordless ...
Foreign residents in GCC countries are now required to obtain e-Visa to visit UAE Foreign residents of Gulf Cooperation Council (GCC) country must obtain an electronic visa before travelling to ...
Eye drug maker Ocuphire Pharma is acquiring gene therapy developer Opus Genetics in an all-stock transaction that will see the commercial-stage company adopt the biotech’s identity. The ...
Filmmaker KE Gnanavel Raja announced that the team is currently planning the film and developing ideas after a significant gap since the first two parts. This careful approach aims to enhance ...
But one of the most powerful aspiring entrants, Novo Nordisk, may not be as intimidating for the biotech as it once was. Novo's molecule semaglutide (commonly known by the trade names Ozempic and ...
Telugu superstar Prabhas is set to celebrate his 45th birthday this Wednesday, and fans are in for a special treat. The producers of his upcoming film The Raaja Saab have announced that they will ...
Sourav Majumdar, Editor of Business Today, has announced his departure from Business Today. In a LinkedIn post Majumdar expressed gratitude for his team’s support and the “priceless ...
European Court Invalidates Harvard Biotech Patent in Three Countries Harvard Medical School is located at 25 Shattuck St, Boston, MA 02115. By Jonathan G. Yuan ...
Since it was founded nearly two decades ago, 23andMe has grown into one of the largest biotechnology companies in the world. Millions of people have used its simple genetic testing service ...
EF Hutton has initiated coverage on ImmunityBio Inc. (NASDAQ:IBRX), a vertically integrated biotechnology company developing therapies and vaccines to bolster the natural immune system for cancers ...
EF Hutton initiated coverage on ImmunityBio (IBRX) with a Buy rating and a $30 price target. ImmunityBio's Anktiva shows high complete response rates in trials, enhancing immunotherapy for BCG ...